Clorox Co (NYSE:CLX) Shares Acquired by D.A. Davidson & CO.

Share on StockTwits

D.A. Davidson & CO. grew its stake in Clorox Co (NYSE:CLX) by 2.9% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 16,648 shares of the company’s stock after acquiring an additional 468 shares during the quarter. D.A. Davidson & CO.’s holdings in Clorox were worth $2,528,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Asahi Life Asset Management CO. LTD. purchased a new position in shares of Clorox during the 2nd quarter worth $340,000. Cambridge Investment Research Advisors Inc. grew its holdings in shares of Clorox by 3.2% during the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 27,406 shares of the company’s stock worth $4,196,000 after purchasing an additional 858 shares during the period. Ontario Teachers Pension Plan Board grew its holdings in shares of Clorox by 209.0% during the 2nd quarter. Ontario Teachers Pension Plan Board now owns 37,846 shares of the company’s stock worth $5,795,000 after purchasing an additional 25,599 shares during the period. CWM LLC grew its holdings in shares of Clorox by 75.6% during the 2nd quarter. CWM LLC now owns 92,127 shares of the company’s stock worth $14,106,000 after purchasing an additional 39,668 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Clorox by 4.2% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 969,843 shares of the company’s stock worth $148,493,000 after purchasing an additional 39,390 shares during the period. Institutional investors and hedge funds own 78.56% of the company’s stock.

A number of brokerages recently commented on CLX. Credit Suisse Group lowered their target price on Clorox from $172.00 to $168.00 and set an “outperform” rating for the company in a report on Thursday, October 3rd. Royal Bank of Canada raised their target price on Clorox to $161.00 and gave the company a “sector perform” rating in a report on Friday, August 2nd. Deutsche Bank lowered their target price on Clorox from $151.00 to $145.00 and set a “hold” rating for the company in a report on Thursday, October 3rd. JPMorgan Chase & Co. reiterated an “underweight” rating and issued a $137.00 price objective (down previously from $143.00) on shares of Clorox in a research note on Thursday, October 3rd. Finally, Zacks Investment Research upgraded Clorox from a “sell” rating to a “hold” rating and set a $175.00 price objective for the company in a research note on Monday, July 29th. Five investment analysts have rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the stock. Clorox currently has an average rating of “Hold” and an average target price of $152.00.

In other Clorox news, SVP Andrew J. Mowery sold 5,648 shares of Clorox stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $146.29, for a total transaction of $826,245.92. Following the transaction, the senior vice president now owns 15,920 shares of the company’s stock, valued at $2,328,936.80. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, SVP Michael R. Costello sold 3,225 shares of Clorox stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $161.34, for a total value of $520,321.50. Following the transaction, the senior vice president now directly owns 29,669 shares in the company, valued at approximately $4,786,796.46. The disclosure for this sale can be found here. Insiders have sold a total of 15,870 shares of company stock worth $2,484,000 in the last three months. Corporate insiders own 1.14% of the company’s stock.

Shares of NYSE CLX opened at $146.28 on Friday. The company has a debt-to-equity ratio of 4.69, a quick ratio of 0.52 and a current ratio of 0.87. Clorox Co has a fifty-two week low of $143.58 and a fifty-two week high of $167.70. The firm has a market capitalization of $18.24 billion, a PE ratio of 23.15, a price-to-earnings-growth ratio of 4.65 and a beta of 0.38. The stock’s 50-day simple moving average is $149.46 and its 200-day simple moving average is $154.15.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, October 31st. The company reported $1.59 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.05. Clorox had a return on equity of 123.56% and a net margin of 13.20%. The business had revenue of $1.51 billion for the quarter, compared to analyst estimates of $1.51 billion. During the same quarter last year, the company earned $1.62 EPS. The business’s quarterly revenue was down 3.6% on a year-over-year basis. On average, sell-side analysts forecast that Clorox Co will post 6.16 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Wednesday, October 30th will be given a dividend of $1.06 per share. This represents a $4.24 annualized dividend and a dividend yield of 2.90%. The ex-dividend date is Tuesday, October 29th. Clorox’s dividend payout ratio (DPR) is presently 67.09%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

See Also: How do buyers and sellers choose a strike price?

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Brokerages Set $5.80 Price Target for VirTra Systems Inc.
Brokerages Set $5.80 Price Target for VirTra Systems Inc.
Zealium Price Hits $0.0014 on Top Exchanges
Zealium Price Hits $0.0014 on Top Exchanges
Stealth  Price Up 9.5% This Week
Stealth Price Up 9.5% This Week
Newton Coin Project Hits 24-Hour Volume of $56.00
Newton Coin Project Hits 24-Hour Volume of $56.00
MediBloc [ERC20] Price Reaches $0.0035
MediBloc [ERC20] Price Reaches $0.0035
Mitie Group  Given “Buy” Rating at Liberum Capital
Mitie Group Given “Buy” Rating at Liberum Capital


© 2006-2019 Ticker Report